Fabre Kramer Pharmaceuticals
Mental Health Care, 5847 San Felipe St, Houston, Texas, 77057, United States, 1-10 Employees
Phone Number: 71********
Who is FABRE-KRAMER PHARMACEUTICALS
Fabre-Kramer Pharmaceuticals, Inc., is a pharmaceutical company which identifies, develops and commercializes psychotropic drugs. The Companys principals have over 40 years of experience ...
Read More
- Headquarters: 5847 San Felipe St, Houston, Texas, 77057, United States
- Date Founded: 1992
- Employees: 1-10
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
- CEO: Steve Kramer
Industry: Mental Health Care
SIC Code: 2834 | NAICS Code: 541110 | Show More
Does something look wrong? Fix it. | View contact records from FABRE-KRAMER PHARMACEUTICALS
Fabre-Kramer Pharmaceuticals Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Fabre-Kramer Pharmaceuticals
Answer: Fabre-Kramer Pharmaceuticals's headquarters are located at 5847 San Felipe St, Houston, Texas, 77057, United States
Answer: Fabre-Kramer Pharmaceuticals's phone number is 71********
Answer: Fabre-Kramer Pharmaceuticals's official website is https://fabrekramer.com
Answer: Fabre-Kramer Pharmaceuticals's revenue is $1 Million to $5 Million
Answer: Fabre-Kramer Pharmaceuticals's SIC: 2834
Answer: Fabre-Kramer Pharmaceuticals's NAICS: 541110
Answer: Fabre-Kramer Pharmaceuticals has 1-10 employees
Answer: Fabre-Kramer Pharmaceuticals is in Mental Health Care
Answer: Fabre-Kramer Pharmaceuticals contact info: Phone number: 71******** Website: https://fabrekramer.com
Answer: Fabre-Kramer Pharmaceuticals, Inc., is a pharmaceutical company which identifies, develops and commercializes psychotropic drugs. The Companys principals have over 40 years of experience in the clinical development of psychotropic drugs and have conducted pivotal studies of many drugs approved by the FDA in psychiatry. They have conducted studies in depression, anxiety, schizophrenia, bipolar disorder, social phobia and sleep disorders. They also have over 40 years of experience in in-patient and out-patient psychiatry, have intimate knowledge of the treatment of Central Nervous System disorders and have analyzed many potential psychotropic compounds from the standpoint of receptor activity, efficacy, tolerability, side effect/benefit ratio, formulation, ease of administration, cost, and ease of manufacturing. At Fabre-Kramer Pharmaceuticals, our goal is to develop and bring to market advanced new medications to help physicians treat their patients unmet medical needs. The Company is in an excellent position to identify and acquire promising psychotropic drugs that, for a variety of reasons, are available from major pharmaceutical companies and other industry and academic sources.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month